199 results on '"Castells, Lluís"'
Search Results
2. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors
3. mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)
4. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy
5. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study
6. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
7. Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients
8. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition
9. VI Consensus Document by the Spanish Liver Transplantation Society
10. VI documento de consenso de la sociedad española de trasplante hepático (SETH)
11. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management
12. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study
13. Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant
14. Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients
15. Impact of Recipient Age on Long-Term after Liver Transplantation: A Double Propensity Score Matching Analysis
16. Efficacy and safety of daclatasvir‐based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
17. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study
18. Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD
19. Impact of Prophylactic Norfloxacin in Multidrug Resistant Bacterial Infections in the Early Liver Posttransplant Period.
20. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients
21. Positive Polymerase Chain Reaction for SARS-CoV-2 in a Candidate Does Not Always Preclude Liver Transplantation: Case Report and Literature Review
22. Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)
23. Spontaneous Portosystemic Shunt Embolization in Liver Transplant Recipients with Recurrent Hepatic Encephalopathy
24. Decreased Long‐Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
25. Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
26. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
27. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
28. Low seroprevalence of SARS‐CoV‐2 antibodies in a liver transplant cohort
29. Long‐term effects of COVID‐19 in solid organ transplantation recipients
30. Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
31. Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: A cohort study
32. Does Routine Abdominal Drain Tip Culture Anticipate Post-Operative Infection in Liver Transplantation?
33. Recurrent Pyogenic Cholangitis as an Unusual Indication for Liver Transplantation in a Center of a Western Country
34. Hemoperitoneum as a First Manifestation of Hepatocellular Carcinoma in Western Patients with Liver Cirrhosis
35. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature
36. Long-Term Outcome of Hepatitis C Virus Infections Acquired After Pediatric Liver Transplantation
37. Routine Bile Culture From Liver Donors as Screening of Donor‐Transmitted Infections in Liver Transplantation
38. Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors
39. Recipient Age for Liver Transplantation: Should It Be Limited? A Propensity Score Matching Analysis of a Large European Series
40. Transition to Adult Care for Pediatric Liver Transplant Recipients
41. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
42. Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
43. Visceral Leishmaniasis Among Liver Transplant Recipients: An Overview
44. Role of Biodegradable Stents as Part of Treatment of Biliary Strictures after Pediatric and Adult Liver Transplantation: An Observational Single-Center Study
45. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial
46. Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction
47. FRI-054-Immune-related hepatitis as an independent entity from autoimmune hepatitis: clinical, prognostic and therapeutic differences
48. FRI-201-Hepatitis B virus vaccine immunogenicity in anti-HBC+ immunocompromised patients with low anti-HBS levels: Preliminary results of the Hepbare study
49. SAT-212-Treatment with mTOR inhibitors is an independent risk factor for chronic hepatitis E in transplant patients with increased transaminases levels
50. Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.